CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-11 | Ho Tony W Executive VP, Head of R&D | Grant or award · Stock Option (Right to Buy) | +23,334 | 23,334 | ||
| 2021-03-11 | Ho Tony W Executive VP, Head of R&D | Grant or award · Restricted Stock Units | +9,000 | 9,000 | ||
| 2021-03-10 | TOMSICEK MICHAEL JOHN Chief Financial Officer | Option exercise | +2,833 | 3,243 | ||
| 2021-03-10 | TOMSICEK MICHAEL JOHN Chief Financial Officer | Shares withheld for taxes | −1,352 | $124.15 | $168K | 1,891 |
| 2021-03-10 | Kulkarni Samarth Chief Executive Officer | Option exercise | +11,833 | 194,024 | ||
| 2021-03-10 | Kulkarni Samarth Chief Executive Officer | Shares withheld for taxes | −5,526 | $124.15 | $686K | 188,498 |
| 2021-03-10 | Klein Lawrence Otto CBO & COO | Option exercise | +4,583 | 15,191 | ||
| 2021-03-10 | Klein Lawrence Otto CBO & COO | Shares withheld for taxes | −2,141 | $124.15 | $266K | 13,050 |
| 2021-03-10 | KASINGER JAMES R. General Counsel and Secretary | Option exercise | +2,833 | 25,264 | ||
| 2021-03-10 | KASINGER JAMES R. General Counsel and Secretary | Shares withheld for taxes | −1,353 | $124.15 | $168K | 23,911 |
| 2021-03-10 | Ho Tony W Executive VP, Head of R&D | Option exercise | +4,583 | 40,445 | ||
| 2021-03-10 | Ho Tony W Executive VP, Head of R&D | Shares withheld for taxes | −2,141 | $124.15 | $266K | 38,304 |
| 2021-03-05 | Ho Tony W Executive VP, Head of R&D | Option exercise | +3,333 | 37,447 | ||
| 2021-03-05 | Ho Tony W Executive VP, Head of R&D | Shares withheld for taxes | −1,585 | $114.65 | $182K | 35,862 |
| 2021-03-01 | Kulkarni Samarth Chief Executive Officer | Shares withheld for taxes | −798 | $130.25 | $104K | 182,191 |
| 2021-03-01 | Bolzon Bradley J PhD Director | Other disposition | −244,056 | 581,999 | ||
| 2021-03-01 | Bolzon Bradley J PhD Director | Other acquisition | +52,716 | 52,716 | ||
| 2021-03-01 | Bolzon Bradley J PhD Director | Other disposition | −7,341 | 16,625 | ||
| 2021-03-01 | Bolzon Bradley J PhD Director | Other acquisition | +1,585 | 54,301 | ||
| 2021-03-01 | Bolzon Bradley J PhD Director | Other disposition | −8,126 | 18,457 |
Page 31 of 46 · 910 trades